TrialCirculation2000

Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.

F Zannad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.